Literature DB >> 8800396

Relative risk for the development of hepatocellular carcinoma in alcoholic patients with cirrhosis: a multiple logistic-regression coefficient analysis.

M Tsutsumi1, M Ishizaki, A Takada.   

Abstract

The hepatitis B virus (HBV) or hepatitis C virus (HVC) markers are frequently positive in alcoholic patients with hepatocellular carcinoma (HCC). However, the role of the relationship between HBV or HCV infection and alcohol drinking in the development of HCC has not been clearly documented. In the present study, the relative risk in 1200 cirrhotic patients with different etiologies who were admitted to five different hospitals in Japan was calculated using the multiple logistic-regression coefficient analysis. In the HCV+ alcohol group, HCC patients tended to be younger, and the odds ratio for the development of HCC was significantly higher compared with the HCV-alone group. Furthermore, the interaction coefficient of alcohol and HCV for the development of HCC was significant statistically. However, the interaction between HBV and alcohol was not significant. Because the proportion of male patients with HCC was significantly higher in the alcohol-alone and HBV-related groups than in the HCV-related group, the multiple logistic-regression analysis was also performed in male patients only. The results were nearly the same as those in male and female patients combined. These results suggest strongly that alcohol and HCV together accelerate the development of HCC. However, a similar relationship was not found between alcohol and HBV.

Entities:  

Mesh:

Year:  1996        PMID: 8800396     DOI: 10.1111/j.1530-0277.1996.tb01683.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  9 in total

1.  Significance of HBV DNA in the hepatic parenchyma from patients with non-B, non-C hepatocellular carcinoma.

Authors:  Takuya Nakai; Osamu Shiraishi; Takashi Kawabe; Hideo Ota; Hiroaki Nagano; Hitoshi Shiozaki
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

2.  Epidemiology of primary and secondary liver cancers.

Authors:  Ashwin Ananthakrishnan; Veena Gogineni; Kia Saeian
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

3.  Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012.

Authors:  Manuela G Neuman; Lawrence Cohen; Samir Zakhari; Radu M Nanau; Sebastian Mueller; Michelle Schneider; Charles Parry; Romina Isip; Helmut K Seitz
Journal:  Alcohol Alcohol       Date:  2014-05-09       Impact factor: 2.826

4.  Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are decreased by alcohol.

Authors:  Masayoshi Yamada; Hisakazu Shiroeda; Ranji Hayashi; Hirokazu Yano; Katsuaki Sato; Mikihiro Tsutsumi; Tomiyasu Arisawa
Journal:  J Clin Biochem Nutr       Date:  2010-04-10       Impact factor: 3.114

5.  Drinking status of heavy drinkers detected by arrival time parametric imaging using sonazoid-enhanced ultrasonography: study of two cases.

Authors:  Noritaka Wakui; Ryuji Takayama; Takahiko Mimura; Naohisa Kamiyama; Kenichi Maruyama; Yasukiyo Sumino
Journal:  Case Rep Gastroenterol       Date:  2011-03-26

6.  Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study.

Authors:  Oh Sang Kwon; Young Kul Jung; Yun Soo Kim; Sang Gyune Kim; Young Seok Kim; Jung Il Lee; Jin Woo Lee; Young Soo Kim; Byung Chul Chun; Ju Hyun Kim
Journal:  Korean J Hepatol       Date:  2010-09

Review 7.  Update on Alcohol and Viral Hepatitis.

Authors:  Stefano Gitto; Giovanni Vitale; Erica Villa; Pietro Andreone
Journal:  J Clin Transl Hepatol       Date:  2014-12-15

8.  A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland.

Authors:  S A McDonald; S J Hutchinson; S M Bird; C Robertson; P R Mills; J F Dillon; D J Goldberg
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

Review 9.  Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era.

Authors:  Heather L Stevenson; Netanya S Utay
Journal:  Trop Dis Travel Med Vaccines       Date:  2016-09-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.